Respirology

COVID-19 chronicles: Evac from the desert
We are unexpectantly travelling today. We have been unceremoniously thrust into an earlier-than-scheduled departure from Palm Springs out of necessity, which some would translate as survival.
COVID-19 drug therapy options: An update
No therapies have been proven effective for preventing or treating COVID-19; however, there are some promising options

Aerosol and fomite transmission SARS-CoV-2 is plausible

NEJM: presence in aerosol of SARS-CoV-2 similar to that of CoV-1
NEJM study finds coronavirus viable in lab-made aerosols for up to three hours

According to experts, the stability of the virus in a real-world environment may differ considerably than what was found in the lab
ER tales: Deciding who is swab-worthy during COVID-19

Russell Greaves is a smart kid. He’s 20, speaks well, tells me exactly what I need to know, and he’s wearing the sweatshirt of my Alma Mater. He was here two days ago with the same symptoms he has today.
Generic versions of Advair Diskus dry powder inhaler now available in Canada

Indicated for use in the maintenance treatment of asthma and chronic obstructive pulmonary disease
Early exposure to household cleaning products is associated with asthma and wheeze in young children

The researchers hypothesize that chemicals in cleaning products may damage the respiratory lining by triggering inflammatory pathways of the immune system
British Columbia soon to implement new restrictions for some codeine-containing liquid preparations

Will require a Controlled Prescription Program duplicate prescription form and storage in a time-delay safe
Are the 2019 GINA asthma strategy recommendations applicable to Canada?

Canadian Thoracic Society poses questions to Chair of GINA Scientific Committee
Updated Canadian Thoracic Society guideline on pharmacotherapy for COPD

Provides guidance and recommendations to optimize pharmacologic therapy for patients with stable chronic obstructive pulmonary disease

COVID-19 chronicles: Evac from the desert

COVID-19 drug therapy options: An update

Aerosol and fomite transmission SARS-CoV-2 is plausible

NEJM study finds coronavirus viable in lab-made aerosols for up to three hours

ER tales: Deciding who is swab-worthy during COVID-19

Generic versions of Advair Diskus dry powder inhaler now available in Canada

Early exposure to household cleaning products is associated with asthma and wheeze in young children

British Columbia soon to implement new restrictions for some codeine-containing liquid preparations

Are the 2019 GINA asthma strategy recommendations applicable to Canada?

Updated Canadian Thoracic Society guideline on pharmacotherapy for COPD